This secondary analysis of predominantly lung cancer patients , consistent with the original analysis , shows no survival advantage for the group overall when treated with WBRT and SRS ; however , in patients with high GPA ( @-@ ) , there is a survival advantage regardless of whether they have @ , @ , or @ BM .